Log in

Relevant bibliographies by topics / Surveillance immune / Journal articles

To see the other types of publications on this topic, follow the link: Surveillance immune.

Journal articles on the topic 'Surveillance immune'

Author: Grafiati

Published: 25 May 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Surveillance immune.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shastri, Nilabh, Chansu Park, and Jian Guan. "Immune surveillance of immune surveillance." Molecular Immunology 150 (October 2022): 2. http://dx.doi.org/10.1016/j.molimm.2022.05.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Swann, Jeremy B., and Mark J. Smyth. "Immune surveillance of tumors." Journal of Clinical Investigation 117, no. 5 (2007): 1137–46. http://dx.doi.org/10.1172/jci31405.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Grossman, Zvi, and Ronald B. Herberman. "‘Immune surveillance’ without immunogenicity." Immunology Today 7, no. 5 (1986): 128–31. http://dx.doi.org/10.1016/0167-5699(86)90075-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Prehn, Richmond T., and Liisa M. Prehn. "The flip side of immune surveillance: immune dependency." Immunological Reviews 222, no. 1 (2008): 341–56. http://dx.doi.org/10.1111/j.1600-065x.2008.00609.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kim, Ryungsa, Manabu Emi, and Kazuaki Tanabe. "Cancer immunoediting from immune surveillance to immune escape." Immunology 121, no. 1 (2007): 1–14. http://dx.doi.org/10.1111/j.1365-2567.2007.02587.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Schaller, Julien, and Judith Agudo. "Metastatic Colonization: Escaping Immune Surveillance." Cancers 12, no. 11 (2020): 3385. http://dx.doi.org/10.3390/cancers12113385.

Full text

Abstract:

Cancer immunotherapy has shifted the paradigm in cancer therapy by revitalizing immune responses against tumor cells. Specifically, in primary tumors cancer cells evolve in an immunosuppressive microenvironment, which protects them from immune attack. However, during tumor progression, some cancer cells leave the protective tumor mass, disseminating and seeding secondary organs. These initial disseminated tumor cells (DTCs) should potentially be susceptible to recognition by the immune system in the new host tissues. Although Natural Killer or T cells eliminate some of these DTCs, a fraction e

APA, Harvard, Vancouver, ISO, and other styles

7

Lowe, Scott. "Immune Surveillance of Senescent Cells." Innovation in Aging 5, Supplement_1 (2021): 246. http://dx.doi.org/10.1093/geroni/igab046.952.

Full text

Abstract:

Abstract Cellular senescence involves a stable cell cycle arrest and a secretory program that modulates the tissue environment. In cancer, senescence acts as a potent barrier to tumorigenesis and, though many cancers evade senescence during the course of tumor evolution, ionizing radiation and conventional chemotherapy can, to varying degrees, induce senescence in tumor cells leading to potent anticancer effects. Conversely, the aberrant accumulation of senescent cells can reduce regenerative capacity and lead to tissue decline, contributing to tissue pathologies associated with age or the deb

APA, Harvard, Vancouver, ISO, and other styles

8

Ahmad, Aamir. "Tumor microenvironment and immune surveillance." Microenvironment and Microecology Research 4, no. 1 (2022): 6. http://dx.doi.org/10.53388/mmr2022006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Oh, Julia, and Derya Unutmaz. "Immune cells for microbiota surveillance." Science 366, no. 6464 (2019): 419–20. http://dx.doi.org/10.1126/science.aaz4014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Zanetti, M., and N. R. Mahadevan. "Immune Surveillance from Chromosomal Chaos?" Science 337, no. 6102 (2012): 1616–17. http://dx.doi.org/10.1126/science.1228464.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Alderton, Gemma. "Immune surveillance of the brain." Science 366, no. 6472 (2019): 1467.18–1469. http://dx.doi.org/10.1126/science.366.6472.1467-r.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Waddell, Nicola, and Venkateswar Addala. "Germline variants alter immune surveillance." Science 384, no. 6699 (2024): 961–62. http://dx.doi.org/10.1126/science.adp7370.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Zinkernagel, Rolf, and Paul Klenerman. "Immune surveillance and AIDS progression." Current Biology 7, no. 7 (1997): R403—R405. http://dx.doi.org/10.1016/s0960-9822(06)00201-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Nagarajan, Niranjana A., and Nilabh Shastri. "Immune surveillance for ERAAP dysfunction." Molecular Immunology 55, no. 2 (2013): 120–22. http://dx.doi.org/10.1016/j.molimm.2012.10.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Schmid, Dorothee, and Christian Münz. "Immune Surveillance via Self Digestion." Autophagy 3, no. 2 (2007): 133–35. http://dx.doi.org/10.4161/auto.3591.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Branch, Pauline, David C. Bicknell, Andrew Rowan, Walter F. Bodmer, and Peter Karran. "Immune surveillance in colorectal carcinoma." Nature Genetics 9, no. 3 (1995): 231–32. http://dx.doi.org/10.1038/ng0395-231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jenne, Craig N., and Paul Kubes. "Immune surveillance by the liver." Nature Immunology 14, no. 10 (2013): 996–1006. http://dx.doi.org/10.1038/ni.2691.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Zanetti, Maurizio. "Chromosomal chaos silences immune surveillance." Science 355, no. 6322 (2017): 249–50. http://dx.doi.org/10.1126/science.aam5331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ferrone, S. "Melanoma, immune surveillance, and immunotherapy." Journal of Clinical Investigation 93, no. 4 (1994): 1351–52. http://dx.doi.org/10.1172/jci117108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Damhofer, Helene, and Kristian Helin. "EZH2i unlocks PDAC immune surveillance." Nature Cancer 4, no. 6 (2023): 781–83. http://dx.doi.org/10.1038/s43018-023-00562-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Caruso, Roberta, and Grace Y. Chen. "High fat stems tumor immune surveillance." Cell Reports Medicine 2, no. 12 (2021): 100483. http://dx.doi.org/10.1016/j.xcrm.2021.100483.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Oluwadara, Oluwadayo O., Andre Barkhordarian, Luca Giacomelli, Xenia Brant, and Francesco Chiappelli. "Immune surveillance of nasopharyngeal carcinoma (NpC)." Bioinformation 7, no. 5 (2011): 271–75. http://dx.doi.org/10.6026/97320630007271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Jobim, Mariana, and Luiz F. J. Jobim. "Natural killer cells and immune surveillance." Jornal de Pediatria 84, no. 7 (2008): 58–67. http://dx.doi.org/10.2223/jped.1780.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Monzavi-Karbassi, Behjatolah, Anastas Pashov, and Thomas Kieber-Emmons. "Tumor-Associated Glycans and Immune Surveillance." Vaccines 1, no. 2 (2013): 174–203. http://dx.doi.org/10.3390/vaccines1020174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Shin, Hwain, Manuela Mally, Marina Kuhn, Cecile Paroz, and Guy R. Cornelis. "Escape from Immune Surveillance byCapnocytophaga canimorsus." Journal of Infectious Diseases 195, no. 3 (2007): 375–86. http://dx.doi.org/10.1086/510243.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Gruenbacher, Georg, and Martin Thurnher. "Mevalonate metabolism governs cancer immune surveillance." OncoImmunology 6, no. 10 (2017): e1342917. http://dx.doi.org/10.1080/2162402x.2017.1342917.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Eiselein, M. W. Biggs and J. E. "Suppression of immune surveillance in melanoma." Medical Hypotheses 56, no. 6 (2001): 648–52. http://dx.doi.org/10.1054/mehy.2000.1211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Smyth, Mark J., Ilia Voskoboinik, and Joseph A. Trapani. "Immune surveillance of lymphoma in humans?" Blood 105, no. 11 (2005): 4159–60. http://dx.doi.org/10.1182/blood-2005-03-1019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

den Hartog, Gerco, Rob van Binnendijk, Anne-Marie Buisman, Guy A. M. Berbers, and Fiona R. M. van der Klis. "Immune surveillance for vaccine-preventable diseases." Expert Review of Vaccines 19, no. 4 (2020): 327–39. http://dx.doi.org/10.1080/14760584.2020.1745071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Agranovich, Alexandra, Tal Vider-Shalit, and Yoram Louzoun. "Optimal viral immune surveillance evasion strategies." Theoretical Population Biology 80, no. 4 (2011): 233–43. http://dx.doi.org/10.1016/j.tpb.2011.08.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Pawelec, Graham. "MHC-Unrestricted Immune Surveillance of Leukemia1." Cancer Biotherapy 9, no. 3 (1994): 265–88. http://dx.doi.org/10.1089/cbr.1994.9.265.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Starck, S. R., S. Cardinaud, and N. Shastri. "Immune surveillance obstructed by viral mRNA." Proceedings of the National Academy of Sciences 105, no. 27 (2008): 9135–36. http://dx.doi.org/10.1073/pnas.0804456105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Mahasa, Khaphetsi Joseph, Rachid Ouifki, Amina Eladdadi, and Lisette de Pillis. "Mathematical model of tumor–immune surveillance." Journal of Theoretical Biology 404 (September 2016): 312–30. http://dx.doi.org/10.1016/j.jtbi.2016.06.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Newcombe, D. S. "Immune surveillance, organophosphorus exposure, and lymphomagenesis." Lancet 339, no. 8792 (1992): 539–41. http://dx.doi.org/10.1016/0140-6736(92)90349-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Chow, Melvyn T., Andreas Möller, and Mark J. Smyth. "Inflammation and immune surveillance in cancer." Seminars in Cancer Biology 22, no. 1 (2012): 23–32. http://dx.doi.org/10.1016/j.semcancer.2011.12.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Noble, Kim A. "Rheumatoid Arthritis: Immune Surveillance Gone Wild?" Journal of PeriAnesthesia Nursing 26, no. 2 (2011): 110–15. http://dx.doi.org/10.1016/j.jopan.2011.01.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kandalaft, Lana E., Gregory T. Motz, Jaikumar Duraiswamy, and George Coukos. "Tumor immune surveillance and ovarian cancer." Cancer and Metastasis Reviews 30, no. 1 (2011): 141–51. http://dx.doi.org/10.1007/s10555-011-9289-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Boyd, Ashleigh S., and Neil P. Rodrigues. "Stem Cells Cycle toward Immune Surveillance." Immunity 48, no. 2 (2018): 187–90. http://dx.doi.org/10.1016/j.immuni.2018.02.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Young, Richard A., and Timothy J. Elliott. "Stress proteins, infection, and immune surveillance." Cell 59, no. 1 (1989): 5–8. http://dx.doi.org/10.1016/0092-8674(89)90861-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Zimmermann, Valerie S., Fabio Benigni, and Anna Mondino. "Immune surveillance and anti-tumor immune responses: an anatomical perspective." Immunology Letters 98, no. 1 (2005): 1–8. http://dx.doi.org/10.1016/j.imlet.2004.09.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Garcia-Lora, Angel, Ignacio Algarra, and Federico Garrido. "MHC class I antigens, immune surveillance, and tumor immune escape." Journal of Cellular Physiology 195, no. 3 (2003): 346–55. http://dx.doi.org/10.1002/jcp.10290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Töpfer, Katrin, Stefanie Kempe, Nadja Müller, et al. "Tumor Evasion from T Cell Surveillance." Journal of Biomedicine and Biotechnology 2011 (2011): 1–19. http://dx.doi.org/10.1155/2011/918471.

Full text

Abstract:

An intact immune system is essential to prevent the development and progression of neoplastic cells in a process termed immune surveillance. During this process the innate and the adaptive immune systems closely cooperate and especially T cells play an important role to detect and eliminate tumor cells. Due to the mechanism of central tolerance the frequency of T cells displaying appropriate arranged tumor-peptide-specific-T-cell receptors is very low and their activation by professional antigen-presenting cells, such as dendritic cells, is frequently hampered by insufficient costimulation res

APA, Harvard, Vancouver, ISO, and other styles

43

Mundhara, Nikita, and Pritam Sadhukhan. "Cracking the Codes behind Cancer Cells’ Immune Evasion." International Journal of Molecular Sciences 25, no. 16 (2024): 8899. http://dx.doi.org/10.3390/ijms25168899.

Full text

Abstract:

Immune evasion is a key phenomenon in understanding tumor recurrence, metastasis, and other critical steps in tumor progression. The tumor microenvironment (TME) is in constant flux due to the tumor’s ability to release signals that affect it, while immune cells within it can impact cancer cell behavior. Cancer cells undergo several changes, which can change the enrichment of different immune cells and modulate the activity of existing immune cells in the tumor microenvironment. Cancer cells can evade immune surveillance by downregulating antigen presentation or expressing immune checkpoint mo

APA, Harvard, Vancouver, ISO, and other styles

44

Kuttke, M., E. Sahin, J. Pisoni, et al. "Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition." OncoImmunology 5, no. 7 (2016): e1164918. http://dx.doi.org/10.1080/2162402x.2016.1164918.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Guan, Jian, Josiah David Peske, Joshua A. Taylor, and Nilabh Shastri. "The nonclassical immune surveillance for ERAAP function." Current Opinion in Immunology 70 (June 2021): 105–11. http://dx.doi.org/10.1016/j.coi.2021.05.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ousman, Shalina S., and Paul Kubes. "Immune surveillance in the central nervous system." Nature Neuroscience 15, no. 8 (2012): 1096–101. http://dx.doi.org/10.1038/nn.3161.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Prolo, P., F. Chiappelli, G. Bernard, et al. "Neuroendocrine-Immune Surveillance of Osteosarcoma: Emerging Hypothesis." Journal of Dental Research 82, no. 6 (2003): 417–21. http://dx.doi.org/10.1177/154405910308200603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Moser, B. "Chemokines: role in inflammation and immune surveillance." Annals of the Rheumatic Diseases 63, suppl_2 (2004): ii84—ii89. http://dx.doi.org/10.1136/ard.2004.028316.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Schmid, D., and C. Münz. "Immune surveillance of intracellular pathogens via autophagy." Cell Death & Differentiation 12, S2 (2005): 1519–27. http://dx.doi.org/10.1038/sj.cdd.4401727.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Palayyan, Salin Raj, Sunil K. Sukumaran, and Abdul Hamid Siddiqui. "Lingual Taste Papillae Contribute to Immune Surveillance." Current Developments in Nutrition 8 (July 2024): 103420. http://dx.doi.org/10.1016/j.cdnut.2024.103420.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!